# Ovariectomy attenuates phenotypes related to Alzheimer’s disease in a preclinical mouse model and in C57BL/6 J mice

**Authors:** Kazuki Fujii, Yumie Koshidaka, Yuko Yanagibashi, Mayumi Adachi, Mina Matsuo, Kimihiro Kimura, Takashi Saito, Takaomi C. Saido, Keizo Takao

PMC · DOI: 10.1038/s41598-025-20006-9 · Scientific Reports · 2025-10-28

## TL;DR

Removing ovaries in mice reduces Alzheimer's-related behaviors and amyloid buildup, suggesting hormonal changes may influence the disease.

## Contribution

This study demonstrates that ovariectomy can attenuate Alzheimer’s disease-related phenotypes in a preclinical mouse model and in wild-type mice.

## Key findings

- Ovariectomy restored anxiety-like behavior in App mutation mice to levels seen in wild-type mice.
- Ovariectomy improved fear memory task performance in both App mutation and wild-type mice.
- Ovariectomy reduced amyloid-β staining in wild-type mice.

## Abstract

Women are at higher risk for Alzheimer’s disease (AD) than men and hormonal changes during perimenopause are considered a risk factor. The relationship between ovarian hormones and AD has been explored using AD animal models, especially through ovariectomy (OVX) in established AD models. The link between early-stage AD and ovarian hormones, however, remains unclear, largely due to the lack of suitable animal models. Appropriate models for studying early-stage AD pathology, treatment, and prevention are critically needed. The App knock-in mouse model, which carries a single amyloid precursor protein (App) gene mutation, effectively reproduces early amyloid AD pathology. To elucidate the relationship between ovarian hormone deficiency and the behavioral phenotypes of a preclinical AD model, we applied a comprehensive behavioral test battery to this mouse model with bilateral OVX. The App mutation reduced anxiety-like behavior and impaired performance in the fear memory task. OVX restored the anxiety-like behavior of the App mutation mice to a level comparable to that in wild-type (WT) mice. Furthermore, OVX enhanced performance in a fear memory task in both genotypes and reduced amyloid-β staining in WT mice. Together, these findings suggest that OVX attenuates AD-related phenotypes in a preclinical AD model and in C57BL/6 J WT mice.

## Linked entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351]
- **Diseases:** Alzheimer’s disease (MONDO:0004975)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}
- **Diseases:** anxiety (MESH:D001007), AD (MESH:D000544), ovarian hormone deficiency (MESH:D010051)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12568933/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12568933/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12568933/full.md

---
Source: https://tomesphere.com/paper/PMC12568933